What is a senescent cell?
Cellular senescence is a biological process in which a cell permanently stops multiplying after a certain number of divisions or repeated stress. This arrest protects against uncontrolled proliferation and tumour development. Senescence is therefore essential to tissue integrity and genetic stability.
With age, however, senescent cells accumulate in tissues. They release chemical signals – cytokines, enzymes and growth factors – collectively called SASP (Senescence-Associated Secretory Phenotype). These alter the local environment and contribute to tissue degradation, chronic inflammation and eventually visible ageing: reduced skin elasticity, slower regeneration and metabolic or vascular disorders.
Senescence was therefore long perceived as purely harmful, causing progressive organ wear and biological decline. Recent research qualifies this view: apparently "useless" cells sometimes play unexpected beneficial roles in tissue maintenance and repair.
Can senescent cells be beneficial?
Recent cell biology and regenerative medicine research revealed a previously little-known aspect. More than remnants of dysfunctional cells, senescence could actively restore tissue balance, particularly in "barrier" organs: skin, lungs and intestine.
During infection, acute inflammation or mechanical injury, some cells temporarily become senescent. This transient process appears to promote healing and reconstruction. Releasing growth factors and immunomodulatory signals, they coordinate responses, attract immune cells, stimulate healthy cell regeneration and help close wounds or restore epithelial barriers.
This reparative function challenges systematic elimination of all senescent cells. Persistent, inactive cells contribute to tissue ageing, but others play occasional roles necessary for physiological balance. Distinguishing pathological and functional senescence is therefore essential.
Senescent cells and the skin
Skin perfectly illustrates this duality. As a contact and protective organ, it experiences ultraviolet radiation, pollution, temperature changes and oxidative stress throughout life. These promote fibroblast, keratinocyte and skin stem cell senescence.
Long-term accumulation alters dermis and epidermis: loss of firmness, wrinkles, slower healing and dull complexion. This is a biological foundation of skin ageing and a major aesthetic medicine concern.
Yet some senescent cells appear to benefit repair. Recent studies show they release growth factors in early healing that stimulate keratinocyte migration and proliferation. Their temporary presence could therefore facilitate skin regeneration after injury.
This ambivalence calls for caution: eliminating all senescent cells could disrupt natural skin balance and regenerative capacity.
Barrier organs: lungs, intestine, epidermis
"Barrier" organs – lungs, skin and intestine – share architecture and function: the first line of bodily defence against external aggressors. Constantly exposed, they require rapid cell renewal and effective regeneration.
Research demonstrates an adaptive role for temporary senescence in these organs. In lungs, for example, some senescent cells appear after injury or acute inflammation. They secrete molecules supporting respiratory epithelium reconstruction and barrier restoration. Once repair is complete, the immune system naturally removes them.
Likewise, intestinal senescence regulates stem cell proliferation. Preventing excessive division reduces tumour risk while maintaining tissue cohesion.
Senescence therefore forms an integral part of tissue homeostasis regulation, rather than simply signifying decline.
Senolytic treatments
Discoveries led to a new treatment category: senolytics, molecules selectively eliminating senescent cells. Several mouse studies showed prolonged lifespan, improved cardiac function and reduced age-related frailty. These results generated immense hope in anti-ageing and longevity medicine.
However, although partial elimination appears beneficial, complete removal could disrupt defence and repair. In several animal models, total absence produced abnormal regeneration or increased infection sensitivity.
These observations recall that senescence is physiological before pathological. Senolytics could become promising tools but must be precisely dosed, targeted and adapted to biological context. Ongoing human research must confirm these hypotheses before medical application.
Senescence, inflammation and aesthetics
Understanding cellular senescence opens aesthetic medicine prospects. Until now, most anti-ageing strategies stimulated regeneration and eliminated "worn-out" cells. It now appears senescence should be regulated rather than systematically opposed.
Combating chronic inflammation, restoring cellular environments and modulating biological signals offer subtler, more effective long-term avenues. Some non-invasive treatments – photobiomodulation, radiofrequency or certain collagen stimulators – act on this regulation, balancing elimination and protection.
The aim extends beyond removing time's marks to restoring harmonious, functional skin physiology. Ageing is a process intelligently supported rather than erased.
Towards considered regenerative medicine
Senescent cell research illustrates living mechanisms' complexity and interdependence. Systematically removing something perceived as harmful often disrupts subtle balance. Senescence is double-edged: harmful when chronic, indispensable when transient and controlled.
Future therapies must consider this ambivalence. Senolytics, tissue regeneration stimulators and aesthetic procedures require an integrative vision respecting biological rhythms.
In aesthetic medicine, this favours considered regeneration: stimulating active cells without exhausting potential, restoring extracellular matrix without damaging deep structures and preserving barrier function while improving appearance.
